The Scientist

» clinical trials and developmental biology

Most Recent

image: FDA Considers Three-Way Babies

FDA Considers Three-Way Babies

By | February 26, 2014

The agency is soliciting opinions on a new technology that has the potential to circumvent mitochondrial diseases by producing embryos using DNA from three people.

1 Comment

image: Opinion: Translational Biotechnology

Opinion: Translational Biotechnology

By | February 17, 2014

Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.

0 Comments

image: Neural Target for Autism?

Neural Target for Autism?

By | February 7, 2014

Mouse and rat models of the developmental disorder responded positively to a drug given to their mothers a day before birth.

0 Comments

image: Unauthorized HIV Trial Leader Fined

Unauthorized HIV Trial Leader Fined

By | February 3, 2014

A Spanish researcher faces a penalty after conducting a study for which he never obtained proper approvals or insurance.

0 Comments

image: Meiosis Maven

Meiosis Maven

By | February 1, 2014

Fueled by her love of visual data and addicted to chromosomes, Abby Dernburg continues to study how homologous chromosomes find each other during gamete formation.

1 Comment

image: Unmasking Secret Identities

Unmasking Secret Identities

By | February 1, 2014

A tour of techniques for measuring DNA hydroxymethylation

2 Comments

image: J&J to Share Trial Data

J&J to Share Trial Data

By | January 31, 2014

The pharmaceutical giant teams up with Yale University to make raw clinical data available to researchers.

0 Comments

image: Stem Cell Trials in Peril?

Stem Cell Trials in Peril?

By | January 27, 2014

The only US firm with an ongoing embryonic stem cell therapy clinical trial is in financial and legal hot water.

2 Comments

image: Fish of Many Colors

Fish of Many Colors

By | January 23, 2014

Researchers seek insight into the pigmentation patterns of guppies and zebrafish.

0 Comments

image: Inconsistent Evidence

Inconsistent Evidence

By | January 22, 2014

More than a third of US drug approvals are based on a single large clinical trial, while others require more in-depth study, according to a new report.

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  3. Most of Human Genome Nonfunctional: Study
  4. Identifying Predatory Publishers
AAAS